North America & Europe Artificial Pancreas Systems Market Growth Driven By High Prevalence of Diabetes

 Artificial pancreas is an insulin pump connected to a continuous glucose monitor. The monitor is controlled via a receiver using sophisticated software algorithms. It is used to help people with type 1 diabetes control their blood sugar levels. Currently available systems only deliver a single enzyme-based hormone insulin. Since the body usually produces insulin naturally, the use of an artificial pancreas can help diabetics lower their need for insulin by lessening the amount of the hormone that is produced and excreted. They are generally less expensive than a manual method.

The growth of North America & Europe Artificial Pancreas Systems Market is driven by high prevalence of diabetes in the regions. For instance, according to International Diabetes Federation’s IDF Diabetes Atlas 2019 Edition, the numbers of adults with diabetes in the U.S. was 31.0 million. In Europe, 59,322,100 suffered from diabetes in 2019 and the number is expected to reach 68,121,400 in 2045.

In most cases, an artificial pancreas will help regulate blood sugar levels by adjusting the insulin dose and timing to compensate for the body's inability to produce the appropriate amount of the hormone. When blood sugar levels are too high, the pancreas releases additional amounts of insulin to help get the blood sugar levels back into a healthy range. When blood sugar levels are too low, the pancreas shuts down production of insulin. The goal of therapy with an artificial pancreas is to help diabetics return their blood sugar levels back into a normal range. If blood sugar levels are too high, there is usually no need for therapy as the body is able to process the insulin itself.

The growth of North America & Europe Artificial Pancreas Systems Market is also driven by approval and launch of new products in the regions. For instance, in January 2020, the U.S. Food and Drug Administration approved an artificial pancreas system – based on technology from the University of Virginia Center for Diabetes Technology – that automatically monitors and regulates blood glucose levels.

Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldEditEdit in GingerEdit in Ginger×Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldEditEdit in GingerEdit in Ginger×